Yun F. Xu

321 Zhongshan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 834 publications

Microglial RIOK3 promotes post-ischemic neuroinflammation by facilitating YBX1 phosphorylation and nuclear accumulation.

Microglial RIOK3 promotes post-ischemic neuroinflammation by facilitating YBX1 phosphorylation and nuclear accumulation.

Journal: Experimental neurology

Published: July 28, 2026

FCE as a Rare Cause of Acute Spinal Cord Infarction With Concomitant Cerebral Infarction.

FCE as a Rare Cause of Acute Spinal Cord Infarction With Concomitant Cerebral Infarction.

Journal: Stroke

Published: July 27, 2026

Sequence-Programmable Iron Oxide Nanoparticles Enable Dual-Phase T1-Weighted MRI of Ultrasmall Hepatocellular Carcinoma and Tumor Vascular Architecture.

Sequence-Programmable Iron Oxide Nanoparticles Enable Dual-Phase T1-Weighted MRI of Ultrasmall Hepatocellular Carcinoma and Tumor Vascular Architecture.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: June 10, 2026

Breaking the Autophagy-Oxidative Stress Vicious Cycle in Alzheimer's Disease: Lactiflorin Unlocks P62 Dual Phosphorylation via ULK1 Targeting.

Breaking the Autophagy-Oxidative Stress Vicious Cycle in Alzheimer's Disease: Lactiflorin Unlocks P62 Dual Phosphorylation via ULK1 Targeting.

Journal: Journal of ethnopharmacology

Published: June 09, 2026

Clinical evaluation of non-intubated spontaneous ventilation video-assisted thoracoscopic surgery in patients with non-small cell lung cancer and compromised pulmonary function: a propensity score-matched analysis.

Clinical evaluation of non-intubated spontaneous ventilation video-assisted thoracoscopic surgery in patients with non-small cell lung cancer and compromised pulmonary function: a propensity score-matched analysis.

Journal: Journal of thoracic disease

Published: June 08, 2026

Novel natural inhibitor Rubimaillin targets NLRP3 R167/Y381 to ameliorate inflammatory and neurodegenerative diseases.

Novel natural inhibitor Rubimaillin targets NLRP3 R167/Y381 to ameliorate inflammatory and neurodegenerative diseases.

Journal: Journal of ethnopharmacology

Published: May 19, 2026

The Dual Roles of Extracellular Vesicle Subtypes in Regulating Traumatic Brain Injury.

The Dual Roles of Extracellular Vesicle Subtypes in Regulating Traumatic Brain Injury.

Journal: International journal of molecular sciences

Published: May 14, 2026

Patterns and correlates of casual sexual behavior through the internet and inconsistent condom use among MSM college students in Zhejiang province, China: a cross-sectional study, 2022.

Patterns and correlates of casual sexual behavior through the internet and inconsistent condom use among MSM college students in Zhejiang province, China: a cross-sectional study, 2022.

Journal: Frontiers in public health

Published: April 20, 2026

A lightweight alignment-aware DBNet for surgical instrument code detection.

A lightweight alignment-aware DBNet for surgical instrument code detection.

Journal: PloS one

Published: April 16, 2026

A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A.

A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A.

Journal: iScience

Published: April 15, 2026

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

Journal: European journal of pharmacology

Published: March 26, 2026

Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma

Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: March 18, 2026

Showing 1-12 of 834

Last Updated: 09/26/2026